Nothing Special   »   [go: up one dir, main page]

DOP2010000373A - Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas - Google Patents

Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas

Info

Publication number
DOP2010000373A
DOP2010000373A DO2010000373A DO2010000373A DOP2010000373A DO P2010000373 A DOP2010000373 A DO P2010000373A DO 2010000373 A DO2010000373 A DO 2010000373A DO 2010000373 A DO2010000373 A DO 2010000373A DO P2010000373 A DOP2010000373 A DO P2010000373A
Authority
DO
Dominican Republic
Prior art keywords
urea
treatment
bacterial infections
heterociclic
derivatives
Prior art date
Application number
DO2010000373A
Other languages
English (en)
Inventor
Brian Sherer
Pamela Hill
John Irvin Manchester
Allison Laura Choy
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40823415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2010000373(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of DOP2010000373A publication Critical patent/DOP2010000373A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DO2010000373A 2008-06-04 2010-12-03 Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas DOP2010000373A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5873608P 2008-06-04 2008-06-04

Publications (1)

Publication Number Publication Date
DOP2010000373A true DOP2010000373A (es) 2011-01-15

Family

ID=40823415

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000373A DOP2010000373A (es) 2008-06-04 2010-12-03 Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas

Country Status (23)

Country Link
US (1) US8283361B2 (es)
EP (1) EP2300463A1 (es)
JP (1) JP2011522026A (es)
KR (1) KR20110014710A (es)
CN (1) CN102105469A (es)
AR (1) AR072045A1 (es)
AU (1) AU2009254930A1 (es)
BR (1) BRPI0915471A2 (es)
CA (1) CA2725568A1 (es)
CL (1) CL2009001349A1 (es)
CO (1) CO6382176A2 (es)
CR (1) CR11825A (es)
DO (1) DOP2010000373A (es)
EA (1) EA201001858A1 (es)
EC (1) ECSP10010664A (es)
IL (1) IL209503A0 (es)
MX (1) MX2010013310A (es)
PE (1) PE20100155A1 (es)
SV (1) SV2010003752A (es)
TW (1) TW201000475A (es)
UY (1) UY31864A (es)
WO (1) WO2009147433A1 (es)
ZA (1) ZA201008610B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100130737A1 (en) * 2005-02-18 2010-05-27 Takeda Pharmaceutical Company Limited Regulating Agent of GPR34 Receptor Function
TW201102065A (en) * 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
US20100317624A1 (en) * 2009-06-08 2010-12-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
CN102844305B (zh) 2010-03-31 2014-07-02 埃科特莱茵药品有限公司 抗菌异喹啉-3-基脲衍生物
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
US11857352B2 (en) 2016-09-06 2024-01-02 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
WO2018074880A2 (ko) * 2016-10-20 2018-04-26 한국화학연구원 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물
CA3057431A1 (en) 2017-03-24 2018-09-27 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
CN111808089B (zh) * 2019-04-10 2023-04-11 四川大学华西医院 一种治疗糖尿病的药物依格列净或其衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000342A1 (en) 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
KR100944645B1 (ko) 2000-12-15 2010-03-04 버텍스 파마슈티칼스 인코포레이티드 자이라제 억제제 및 이를 포함하는 약제학적 조성물
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
WO2006092599A2 (en) * 2005-03-04 2006-09-08 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
US8022816B2 (en) 2005-03-21 2011-09-20 Vela Systems, Inc. System and method for field management using radio frequency tags
US7569907B2 (en) 2005-03-28 2009-08-04 Cooper Technologies Company Hybrid chip fuse assembly having wire leads and fabrication method therefor
JP2008538047A (ja) 2005-04-13 2008-10-02 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 位相変調に先立つ透かし入れのあるエンコード
AU2006328196A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
DE102006012337B3 (de) 2006-03-17 2007-11-29 Amphenol-Tuchel Electronics Gmbh Elektrischer Steckverbinder
KR20090086629A (ko) * 2006-12-04 2009-08-13 아스트라제네카 아베 항박테리아성 폴리시클릭 우레아 화합물
CN201038186Y (zh) 2007-03-08 2008-03-19 鹤山丽得电子实业有限公司 一种大功率led
TW200940537A (en) * 2008-02-26 2009-10-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2009110688A2 (ko) 2008-03-06 2009-09-11 Jang Gum Sik 태양광 발전 장치
US20100317624A1 (en) * 2009-06-08 2010-12-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof

Also Published As

Publication number Publication date
MX2010013310A (es) 2011-03-01
BRPI0915471A2 (pt) 2017-06-27
EA201001858A1 (ru) 2011-08-30
AR072045A1 (es) 2010-08-04
KR20110014710A (ko) 2011-02-11
AU2009254930A1 (en) 2009-12-10
CL2009001349A1 (es) 2010-12-31
PE20100155A1 (es) 2010-03-25
CR11825A (es) 2011-02-04
TW201000475A (en) 2010-01-01
US20100190745A1 (en) 2010-07-29
EP2300463A1 (en) 2011-03-30
CA2725568A1 (en) 2009-12-10
ECSP10010664A (es) 2011-01-31
JP2011522026A (ja) 2011-07-28
US8283361B2 (en) 2012-10-09
WO2009147433A1 (en) 2009-12-10
IL209503A0 (en) 2011-01-31
UY31864A (es) 2010-01-29
ZA201008610B (en) 2012-08-29
CN102105469A (zh) 2011-06-22
CO6382176A2 (es) 2012-02-15
SV2010003752A (es) 2011-04-14

Similar Documents

Publication Publication Date Title
ES2898695T8 (es) Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
CR11019A (es) 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
ZA201005798B (en) Treatment of microbial infections
BRPI0911577A8 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0923567A2 (pt) agentes antibactericidas novos para o tratamento de infecções gram positivas
BRPI0821258A2 (pt) Derivados de ciclopropilamina
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
BR112012008959A2 (pt) tratamento de terapia de combinação para infecções virais
BR112012004676A2 (pt) método de tratar infecções orotomixovirais.
BRPI0924107A2 (pt) inibidores de hsp90 para tratamento terapêutico
BRPI0911991A2 (pt) derivados de 5-hidroximetil-oxazolidin-2-ona para o tratamento de doenças intestinais bacterianas
BRPI1014767A2 (pt) métodos de tratamento de infecções bacterianas usando oritavancina
BR112012002267A2 (pt) compostos para o tratamento de inflamação.
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
BRPI0822292A2 (pt) Fármaco-alvo eficaz para o tratamento de tuberculose
ZA201104003B (en) Drug for treating infections
GB0801768D0 (en) Treatment of microbial infections
ES1071986Y (es) Dispositivo para el tratamiento de la precombustion
ES1062758Y (es) Estructura de batea para el cultivo del mejillon
ES1071390Y (es) Aparato para el tratamiento de ciatica, lumbociatica y epicondilitis.